Empower Clinics Inc.

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, EXE.TO has a market cap of 2.5B. Regarding current trading prices, EPW.CN is priced at CA$0.04, while EXE.TO trades at CA$27.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas EXE.TO's P/E ratio is 24.13. In terms of profitability, EPW.CN's ROE is +0.47%, compared to EXE.TO's ROE of +0.48%. Regarding short-term risk, EPW.CN is less volatile compared to EXE.TO. This indicates potentially lower risk in terms of short-term price fluctuations for EPW.CN.Check EXE.TO's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, SIA.TO has a market cap of 2.2B. Regarding current trading prices, EPW.CN is priced at CA$0.04, while SIA.TO trades at CA$22.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas SIA.TO's P/E ratio is 45.02. In terms of profitability, EPW.CN's ROE is +0.47%, compared to SIA.TO's ROE of +0.07%. Regarding short-term risk, EPW.CN is less volatile compared to SIA.TO. This indicates potentially lower risk in terms of short-term price fluctuations for EPW.CN.Check SIA.TO's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, DNTL.TO has a market cap of 2.1B. Regarding current trading prices, EPW.CN is priced at CA$0.04, while DNTL.TO trades at CA$11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas DNTL.TO's P/E ratio is -78.57. In terms of profitability, EPW.CN's ROE is +0.47%, compared to DNTL.TO's ROE of -0.02%. Regarding short-term risk, EPW.CN is less volatile compared to DNTL.TO. This indicates potentially lower risk in terms of short-term price fluctuations for EPW.CN.Check DNTL.TO's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, WELL.TO has a market cap of 993.8M. Regarding current trading prices, EPW.CN is priced at CA$0.04, while WELL.TO trades at CA$3.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas WELL.TO's P/E ratio is -129.67. In terms of profitability, EPW.CN's ROE is +0.47%, compared to WELL.TO's ROE of -0.01%. Regarding short-term risk, EPW.CN is less volatile compared to WELL.TO. This indicates potentially lower risk in terms of short-term price fluctuations for EPW.CN.Check WELL.TO's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, DR.TO has a market cap of 303.3M. Regarding current trading prices, EPW.CN is priced at CA$0.04, while DR.TO trades at CA$16.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas DR.TO's P/E ratio is 15.27. In terms of profitability, EPW.CN's ROE is +0.47%, compared to DR.TO's ROE of +0.28%. Regarding short-term risk, EPW.CN is less volatile compared to DR.TO. This indicates potentially lower risk in terms of short-term price fluctuations for EPW.CN.Check DR.TO's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, CRRX.TO has a market cap of 227.1M. Regarding current trading prices, EPW.CN is priced at CA$0.04, while CRRX.TO trades at CA$3.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas CRRX.TO's P/E ratio is 8.83. In terms of profitability, EPW.CN's ROE is +0.47%, compared to CRRX.TO's ROE of +0.28%. Regarding short-term risk, EPW.CN is less volatile compared to CRRX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for EPW.CN.Check CRRX.TO's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, AIDX.TO has a market cap of 225.9M. Regarding current trading prices, EPW.CN is priced at CA$0.04, while AIDX.TO trades at CA$0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas AIDX.TO's P/E ratio is -5.13. In terms of profitability, EPW.CN's ROE is +0.47%, compared to AIDX.TO's ROE of -0.39%. Regarding short-term risk, EPW.CN is less volatile compared to AIDX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for EPW.CN.Check AIDX.TO's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, DRDR.TO has a market cap of 49.4M. Regarding current trading prices, EPW.CN is priced at CA$0.04, while DRDR.TO trades at CA$0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas DRDR.TO's P/E ratio is -0.83. In terms of profitability, EPW.CN's ROE is +0.47%, compared to DRDR.TO's ROE of -1.02%. Regarding short-term risk, EPW.CN is less volatile compared to DRDR.TO. This indicates potentially lower risk in terms of short-term price fluctuations for EPW.CN.Check DRDR.TO's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, GTMS.TO has a market cap of 28.6M. Regarding current trading prices, EPW.CN is priced at CA$0.04, while GTMS.TO trades at CA$0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas GTMS.TO's P/E ratio is -0.45. In terms of profitability, EPW.CN's ROE is +0.47%, compared to GTMS.TO's ROE of +15.74%. Regarding short-term risk, EPW.CN is less volatile compared to GTMS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for EPW.CN.Check GTMS.TO's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, NUMI.TO has a market cap of 16M. Regarding current trading prices, EPW.CN is priced at CA$0.04, while NUMI.TO trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas NUMI.TO's P/E ratio is -0.63. In terms of profitability, EPW.CN's ROE is +0.47%, compared to NUMI.TO's ROE of +11.51%. Regarding short-term risk, EPW.CN and NUMI.TO have similar daily volatility (0.00).Check NUMI.TO's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, CALM.CN has a market cap of 2.8M. Regarding current trading prices, EPW.CN is priced at CA$0.04, while CALM.CN trades at CA$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas CALM.CN's P/E ratio is -0.11. In terms of profitability, EPW.CN's ROE is +0.47%, compared to CALM.CN's ROE of +3.14%. Regarding short-term risk, EPW.CN and CALM.CN have similar daily volatility (0.00).Check CALM.CN's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, OMIC.CN has a market cap of 2.3M. Regarding current trading prices, EPW.CN is priced at CA$0.04, while OMIC.CN trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas OMIC.CN's P/E ratio is -4.50. In terms of profitability, EPW.CN's ROE is +0.47%, compared to OMIC.CN's ROE of -0.83%. Regarding short-term risk, EPW.CN and OMIC.CN have similar daily volatility (0.00).Check OMIC.CN's competition here

EPW.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPW.CN stands at 4.1M. In comparison, MEDI.NE has a market cap of 17.8K. Regarding current trading prices, EPW.CN is priced at CA$0.04, while MEDI.NE trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPW.CN currently has a P/E ratio of -0.27, whereas MEDI.NE's P/E ratio is -0.02. In terms of profitability, EPW.CN's ROE is +0.47%, compared to MEDI.NE's ROE of N/A. Regarding short-term risk, EPW.CN is less volatile compared to MEDI.NE. This indicates potentially lower risk in terms of short-term price fluctuations for EPW.CN.Check MEDI.NE's competition here